Assessment of the occurrence and factors influencing hepatitis B, hepatitis C, and liver damage in individuals with HIV undergoing antiretroviral treatment in Ghana's Upper East Region - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of the occurrence and factors influencing hepatitis B, hepatitis C, and liver damage in individuals with HIV undergoing antiretroviral treatment in Ghana's Upper East Region

  • By

  • Francis Yennube Duut

  • Samuel Punignan Nfoke

  • Elvis Ayamga

  • Naja Kwayaja

  • Dodzi Kwaku Jnr Senoo

  • Godfred Agongo

  • James Abugri

  • Sylvester Donne Dassah

  • February 5, 2026

Share

  • 1

    Hepatitis B and C co-infections significantly impact individuals with HIV, exacerbating liver damage and complicating antiretroviral therapy decisions.

  • 2

    In Ghana, approximately 13.6% of people living with HIV are co-infected with chronic hepatitis B, while hepatitis C co-infection rates are generally lower.

  • 3

    The study found high seroprevalence rates of HBV (15.6%) and HCV (8.4%) among PLHIV in Ghana's Upper East Region, highlighting the need for routine screening.

  • 4

    Antiretroviral therapy can lead to liver injury, necessitating careful selection of treatment regimens for co-infected patients to minimize hepatotoxicity.

  • 5

    The research aims to provide epidemiological data to improve HIV care practices and reduce liver-related morbidity in the Upper East Region of Ghana.

Original Source(s)

Assessment of the occurrence and factors influencing hepatitis B, hepatitis C, and liver damage in individuals with HIV undergoing antiretroviral treatment in Ghana's Upper East Region

  • by Francis Yennube Duut, Samuel Punignan Nfoke, Elvis Ayamga, Naja Kwayaja, Dodzi Kwaku Jnr Senoo, Godfred Agongo, James Abugri, Sylvester Donne Dassah

  • February 5, 2026

Related Content

Telomere Length as a Potential Biomarker for Hepatocellular Carcinoma: A Comparative Analysis of Patients with HCV Treated with Direct Antiviral Agents

Hospital AI Fails to Flag Drug Diversion

"I've never myself seen these technologies be called out in that specific way"

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.